About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials | 16,782 Studies Recruiting

Clinical TrialsBreast Cancer

Breast Cancer Clinical Trials

Browse 16,782 clinical trials for breast cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 9941-9960 of 16,782 trials

CompletedRandomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast CancerTo compare the sequential administration of exemestane with administration of further tamoxifen until 5 years in postmenopausal women with operable breast cancer who have already…NCT00038467·Birmingham, Alabama and 376 others

Related Searches

breast carcinomatrials

Data from ClinicalTrials.govTerms

CompletedFirst-Line Dual Versus Single HER2-Targeted Therapy With Docetaxel for Advanced HER2-Positive Breast CancerThis retrospective observational cohort study emulates a target trial to compare the effectiveness and safety of two first-line treatment strategies for women with HER2-positive…NCT07829900·Nanjing, Jiangsu

CompletedComparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast CancerThis clinical trial will enroll up to 130 adult women with a confirmed diagnosis of clinical stage 1 or 2 breast cancer who are undergoing breast cancer surgery with lumpectomy or…NCT02419807·Cleveland, Ohio

UnknownPhase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer PatientsSurvival benefit and quality of life are two key elements that should be kept in mind in the treatment of metastatic breast cancer.NCT03913234·Seoul

Active not recruitingPreoperative Evaluation of 3D Reconstruction Tool for Nipple-sparing MastectomyThe goal of this clinical study is to explore whether preoperative application of 3D reconstruction tool can reduce the occurrence of ischemic complications in the flap and nipple…NCT06071234·Guangzhou, Guangdong

CompletedCoagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal TherapyThe objective of the study is to monitor the changes of blood coagulation parameters in postmenopausal patients who are treated with adjuvant Hormonal Therapy for a total of 5…NCT00814034·Athens, Attica and 1 other

TerminatedAn Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast CancerEvaluate the feasibility of translating preclinical Chemical Exchange Saturation Transfer (CEST) MRI protocol designed to estimate tumor extracellular pH (pHe) to a clinical MRI…NCT02380209·Tucson, Arizona

TerminatedDocetaxel With or Without a Phytochemical in Treating Patients With Breast CancerRATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00852332·Clermont-Ferrand

CompletedTeam Based Psychosocial Care to Promote, Maintain and Restore Wellness of Breast Cancer PatientsResearchers are trying to see if proactive identification and team based individualized care of cancer patients having emotional difficulties can improve quality of life relative…NCT03770598·Jacksonville, Florida

CompletedDenosumab and MRI Breast ImagingThis is a non-randomized phase II trial of denosumab at 120 mg subcutaneous injection monthly in pre- and post-menopausal women diagnosed with stage 0-III breast cancer who are…NCT02613416·Stony Brook, New York

SuspendedMultiparametric MRI as a Non-Invasive Biomarker of the Tumor MicroenviromentThis study is looking at how an imaging test could help doctors understand if a patient with early breast cancer will respond to drugs that use the patient's immune system to…NCT04803084·Nashville, Tennessee

CompletedMayo Designed Soft Tissue Ultrasound-Detectable MarkerResearchers are trying to determine if the Mayo marker is easily seen with ultrasound making it easier, faster, and more accurate for preoperative localization of the biopsied…NCT04674852·Rochester, Minnesota

CompletedDose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast CancerThe purpose of this study is to assess the feasibility of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate for adjuvant treatment of early stage breast…NCT01328249·Lebanon, New Hampshire and 1 other

RecruitingDiagnostic Prediction Model for De Novo Metastatic Breast CancerThe goal of this observational study is to create a tool to estimate the risk of macroscopic distant tumor spread in women with newly diagnosed breast cancer.NCT07752238·Szombathely, Vas County

CompletedHELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin TherapyThis observational study will evaluate the efficacy, safety and patient reported quality of life of palliative first-line Perjeta (pertuzumab) in combination with Herceptin…NCT01777958·Frankfurt

UnknownThe Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast CancerBreast cancer take a leading position in the structure of morbidity and mortality from malignant tumors among women.NCT04753177·St-Peterburg

CompletedAfimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense BreastThis randomized phase II trial studies how well afimoxifene works in reducing the risk of breast cancer in women with mammographically dense breast.NCT03063619·Tampa, Florida and 4 others

RecruitingTreatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity TestingHistorically, serial testing of patients with metastatic breast cancer has included a combination of physical exam, symptom evaluation, laboratory testing, and imaging.NCT04968964·St Louis, Missouri

WithdrawnMetastatic Breast Cancer Treatment PlanningThe overarching objective of this study is to close clinical knowledge and performance gaps by providing oncology clinicians with the latest advances and emerging research in the…NCT03127332

UnknownEndostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast CancerThis research study is studying endostar in combination with chemotherapy as a possible treatment for HER-2 negative advanced breast cancer.NCT03907098·Hangzhou, Zhejiang

PreviousPage 498 of 840Next